MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'BioHealth Investor' source. Tue, 16 Mar 2010 16:37:13 +0100 http://www.medworm.com/index.php?rid=3368478&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FMc011vwlXB4%2Fsequenom-still-seeks-downs-syndrome-grail-sqnm.html Sequenom, Inc. (NASDAQ: SQNM) is trading lower in the after-hours session after the troubled diagnostics company reported its year-end earnings.  Because of its recent woes of 2009, the earnings and revenue reports are a true side-show compared to what the company is updating over its pipeline and over its products. We would note that actual trading could whip around significantly during the company’s conference call due to very speculative nature of the company and due to its trading history in 2009 and so far in 2010. The company gave a T21 (Down syndrome) update, and it does not sound like the company is throwing in the towel here nor anything at all like it is backing off… This is the biggest issue, or has been, for the company.  At least that is our take.  Sequenom said... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3368478 Mon, 15 Mar 2010 20:29:43 +0100 3368478 http://www.medworm.com/index.php?rid=3368479&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FaW_N_UxGfdw%2Fosi-cant-stay-indpendent-forever-osip.html OSI Pharmaceuticals Inc. (NASDAQ: OSIP) is holding up yet again, despite the notion that Astellas Pharma, Inc. of Japan wants to acquire the company.  OSI decided to formally reject the $52.00 per share tender offer and is recommending that its shareholders reject the offer while it contacts other parties.  Today we have a counter-response from Astellas.  The profitable maker of Tarceva either wants to remain independent regardless of its notion that it will contact outside parties, or it wants to fetch a much higher price.  Based upon a $52.00 deal offer and a current price of about $58.00 after the fact, take a guess what the market is thinking. Astellas has said that it is pleased that OSI’s board of directors has finally instructed its management to explore a transaction for the ... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3368479 Mon, 15 Mar 2010 18:55:09 +0100 3368479 http://www.medworm.com/index.php?rid=3365090&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fb6ks5uOSlZs%2Fsavient-gout-and-fda-back-at-the-door-svnt.html Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is from giving up on its KRYSTEXXA as a gout treatment.  This morning the company announced that it has resubmitted its Biologics License Application to the FDA.  This has been in the news, particularly since the company announced a secondary offering late last year after the FDA denied this in August and sent shares down 35% at the time.  This one even got on the map as an old Jim Cramer favorite. The resubmission is for KRYSTEXXA to treat chronic gout in patients refractory to conventional therapy, which is effectively in patients who have failed to normalize their levels of serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose.  It also for patie... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3365090 Mon, 15 Mar 2010 14:07:10 +0100 3365090 http://www.medworm.com/index.php?rid=3352472&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fd8SmercGAgI%2Fhigh-hopes-on-ariad-aria-mrk.html Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is seeing elevated trading today after a presentation and ahead of earnings. The difference here is that Ariad’s increased trading is in both the stock and in the bonds. Joe Kunkle of OptionsHawk.com noted, “implied volatility is 10% higher to 87.8% as shares gain 2.7%, 4,140 calls trading, 4X average, with buyers of April $3 and May $3.50 calls. Shares are at 52 week highs and breaking a long term downtrend, trading as high as $7.50 in 2005. The Company is expected to announce earnings on March 16th and presented at the Cowen Healthcare Conf. This morning. Ariad’s leukemia drug recently received orphan drug status adn is expected to announce Phase 3 results for its soft tissue and bone sarcoma drug, ridaforolimus. Ariad has a $1... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3352472 Wed, 10 Mar 2010 20:02:44 +0100 3352472 http://www.medworm.com/index.php?rid=3348784&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FXH9WFuvcw7w%2Fmore-drug-and-biohealth-dividends-mrx-wcrx-amgn-mrk-pfe-pph-bbh.html Medicis (NYSE: MRX), a specialty pharmaceutical company in treatments of dermatological and aesthetic conditions, has the talk going again about dividends in the drug and biotech sector.  The company declared a quarter-end cash quarterly dividend of $0.06 payable on April 30, 2010 for holders of record at the close of business on April 1, 2010.  This dividend hike is a 50% increase versus the previous $0.04 dividend and the last hike was in March 2008.  But what is more important than Medicis is that this brings up the focus on dividends in both the pharma sector and potentially in the biotech sector. Many investors have seen scores of dividend hikes since the end of December, which is the yardstick for a vote of confidence issued by a company.  We have noted two more dividend candidat... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3348784 Wed, 10 Mar 2010 15:08:16 +0100 3348784 http://www.medworm.com/index.php?rid=3348785&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FtHaz_ZI2xno%2Fthe-facet-biotech-buyout-saga-fact-biib-abt-pdli.html Facet Biotech Corporation (NASDAQ: FACT) is a buyout saga that seemed as though it would never end in 2009.  The company is now finally being acquired, but not by Biogen Idec (NASDAQ: BIIB).  Abbott Laboratories (NYSE: ABT) announced last night that it entered into a definitive agreement for $27.00 per share in a cash buyout.  The deal is valued at $722 million, but that includes about $272 million in cash and equivalents. The net cost will be about $450 million. In late-2009, Facet turned down a second unsolicited offer from Biogen Idec of $17.50 a share after having rejected a lower offer before that. Facet has discovery and development partnerships with Biogen Idec for MS, and it also has partnerships with PDL BioPharma (NASDAQ: PDLI) and Roche. Facet shares are up 66% at $26.96 this... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3348785 Wed, 10 Mar 2010 13:30:32 +0100 3348785 http://www.medworm.com/index.php?rid=3348786&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F6OmbzTWGBEI%2Fedap-tms-back-on-the-map-edap.html EDAP TMS SA (NASDAQ: EDAP) is a French company which makes medical devices for the treatment of urological diseases and the company’s stock is soaring after the company was granted marketing approval of its newly designed, high-end Sonolith I-Sys lithotripsy device by the Japanese Administration.  Because this market is still under-served, we wanted to look into the news despite this not being a drug or biotech company. The Japanese equivalent of the FDA in the US granted marketing approval of EDAP’s Sonolith I-Sys lithotripsy device. What makes this unique is that the lithotripsy market in Japan is supposed to rank as the number one market in the world in total lithotripsy sales volume and in the installed base. The company also noted that Japanese physicians have traditional... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3348786 Tue, 09 Mar 2010 18:20:22 +0100 3348786 http://www.medworm.com/index.php?rid=3345069&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fv4suQ2DMW5c%2Famylin-friends-brace-for-diabetes-review-amln-lly-alks.html Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) has a big event on deck this week.  This Friday, March 12, is its Prescription Drug User Fee Act (PDUFA) action date for an FDA panel to issue a recommendation on Byetta as the the first once a week treatment for Type II diabetes.  The date had been moved due to recent weather closures in February in and around Washington D.C. Analysts are mixed on the stock with BMO cutting its rating last week, but there were two positive calls from Credit Suisse and Jesup & Lamont. Options are elevated today, but not overly active.  The open interest of stock options is also large enough that the $20 synthetic options straddle would imply that shares have to rise above $24.70 or drop below $15.30 to be profitable. Byetta is already sold with Eli Lilly &... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3345069 Mon, 08 Mar 2010 19:44:23 +0100 3345069 http://www.medworm.com/index.php?rid=3339316&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F_hRGcdC5o70%2Fthe-changing-landscape-of-biotech-valuations-acor-cbst-mnkd-incy-sgen-itmn-ipxl-mrx-svnt-vphm.html The biotech and biohealth universe is changing in size.  In 2008 and 2009, partly due to mergers and partly due to market valuations, there had become a surprisingly small number of biotech stocks which had market capitalization rates of more than $1 billion.  At one point there were only about 10 or 11 in our universe of biotech stocks that actually had market caps which were very far north of $1 billion, or at least out of the biotech stocks which followed at BioHealth Investor. We have recently seen Acorda Therapeutics, Inc. (NASDAQ: ACOR), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), MannKind Corporation (NASDAQ: MNKD), Incyte Corporation (NASDAQ: INCY), Seattle Genetics, Inc. (NASDAQ: SGEN), InterMune, Inc. (NASDAQ: ITMN), Impax Laboratories Inc. (NASDAQ: IPXL), and Medicis Pharmaceu... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3339316 Sat, 06 Mar 2010 20:12:01 +0100 3339316 http://www.medworm.com/index.php?rid=3337143&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FqVmtBh5s9zI%2Fwhen-biotech-layoffs-come-xnpt.html When conglomerates and consumer products lay off workers and employees, shareholders generally cheer the company for saving money and cutting costs by figuring out productivity measures that milk more output per employee.  That leaves more income and ultimately brings more dividends down the road.  But biotech firms are far from being thought of in the same light.  These are growth stories and investors generally get more excited about expanding operations.  So here comes XenoPort, Inc. (NASDAQ: XNPT) announcing on a Friday that HALF of its workers just won the pink-slip lotto ticket from the HR department.  Today just officially became National Employee Morale Day at XenoPort. XenoPort just announced a restructuring plan today that more narrowly focuses its R&D pipeline, and one ... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3337143 Fri, 05 Mar 2010 19:34:55 +0100 3337143 http://www.medworm.com/index.php?rid=3337144&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FJeVxyISe8qA%2Fwinning-from-boosting-good-cholesterol-rvxcf-rvx-pfe-azn-mrk.html BioHealthInvestor usually sticks to US companies or at least sticks to ADRs for investors.  But sometimes there is a much larger bit of data either north of the border or in Europe.  There is a company called  Resverlogix Corp. which trades in Canada under the ticker ‘RVX’ and the stock also trades in the US on the Pink Sheets under the ticker ‘RVXCF.’  The stock is soaring today after Bloomberg gave a very positive article highlighting the merits of the company’s RVX-208.  This potential drug candidate is targeting atherosclerosis in acute coronary syndrome patients.  The target is to raise HDL levels to effectively reverse arterial plaque buildup.  The company noted that there are approximately 350 million patients that require treatment for atheroscl... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3337144 Fri, 05 Mar 2010 16:13:34 +0100 3337144 http://www.medworm.com/index.php?rid=3329473&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FL26MvYzmvJg%2Ftaking-biotech-etfs-ishares-nasdaq-biochnology-to-100-ibb-osip-mdvn.html Today’s price moves in the biotech sector are quite different from what we saw earlier this week.  A hostile merger via tender from Astellas for OSI Pharmaceuticals Inc. (NASDAQ: OSIP) got everyone up in arms this week.  So much that other investors were going back over buyout candidate notes.  We also gave a list of those recently noted biotech buyout candidates this week. But today’s news out of Medivation, Inc. (NASDAQ: MDVN) severely missing its endpoints in the Phase III targets for Dimebon as a new potential blockbuster to treat Alzheimer’s Disease has everyone reminded of the risks in betting on speculative biotech stocks with no products on the market.  That has a sentiment reversal taking place, and unfortunately Dimebon has become Dime-Bag. But before this m... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3329473 Wed, 03 Mar 2010 20:49:18 +0100 3329473 http://www.medworm.com/index.php?rid=3325325&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FnOoVFXYHkoA%2Fbiotech-implosion-medivation-alzheimers-beats-drug-mdvn-pfe.html Medivation, Inc. (NASDAQ: MDVN) is the next biotech implosion.  The company’s highly awaited Phase III study on its Alzheimer drug called Dimebon did not meet expectations. It failed to meet primary and secondary endpoints. The problem is that this was hitting 52-week highs yesterday. The company did note that a separate Phase 3 safety study demonstrated Dimebon’s tolerability when used alone or in combination with approved Alzheimer’s Disease medicines.  Just one more problem… if it doesn’t work it doesn’t matter how tolerable it is.  In some cases the placebo group even did better on the sugar pill, which is perhaps the worst endorsement a company can get. Pfizer Inc. (NYSE: PFE) is also indicated lower this morning as well as it was Medivation’s part... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3325325 Wed, 03 Mar 2010 13:36:56 +0100 3325325 http://www.medworm.com/index.php?rid=3320362&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fh5eFP-FLsus%2Fmore-biotech-buyout-or-ma-targets-osip-vrtx-auxl-itmn-hgsi-celg-dndn-enzn-fact-pbe-xbi.html After today’s hostile Astellas offer for OSI Pharmaceuticals (NASDAQ: OSIP), we have investors and traders alike looking for ‘the next takeover target’ in biotech.  Buy now you know that there are many pitfalls in simply looking for biotech stocks to buy because they will be taken over.  We have taken a look through our own recent stocks noted as takeover candidates and even gone through some sites of our partners looking through potential takeover candidates in the space. Morningstar just last week had a short video with some key potential buyout targets in the biotech space.  It noted Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), and InterMune Inc. (NASDAQ: ITMN).  Those are all names that have come up as takeout t... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3320362 Mon, 01 Mar 2010 18:06:39 +0100 3320362 http://www.medworm.com/index.php?rid=3317389&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F8CyBL87bbQg%2Fhostile-mergers-back-in-biotech-osip.html Mergers are back in biotech…. Astellas Pharma Inc., a global pharmaceutical company in Japan, announced that it will commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals (NASDAQ: OSIP).  The direct tender is nothing short of a hostile merger after Astellas said that OSI has refused to discuss terms. The offer is for $52.00 per share in cash valued at approximately $3.5 billion on a fully diluted basis.  Astellas notes that this offer is premium of over 40% to the recent closing stock price and it is a 53% premium over the three-month average share price.  The deal is also said to not be suject to any financing terms or conditions. In the deal, Astellas hopes to build a world-class oncology platform and expects to invest in OSI’s bu... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3317389 Mon, 01 Mar 2010 13:20:27 +0100 3317389 http://www.medworm.com/index.php?rid=3317390&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FtHxM1ekX4Ig%2Fgeneric-drug-wars-is-dr-reddys-the-answer-rdy-teva-gsk.html Generic drugs are just one of the many combined issues that are coming front and center in the world of healthcare reform.   Frankly this is not a new notion.  Not all.  This weekend came a feature in Barron’s “Asian Trader: Pill Maker That’s Set To Pop” calling Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) of India the next big drug play for investors.  We wanted to look closer under the hood here. The Indian generic drug company’s ADR closed at $24.61 Friday and Barron’s noted two analysts with big price targets: one giving it room up to $29.63 and and another implied rupee price we pegged around $30.82. Sales are expected to approximately double to around $3 billion by 2013 and the waves of name brand drugs coming off patent in the U.S. may off... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3317390 Sun, 28 Feb 2010 19:34:21 +0100 3317390 http://www.medworm.com/index.php?rid=3296734&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FDJB1gd7cZxU%2Fintermune-volatility-compression-itmn.html InterMune Inc. (NASDAQ: ITMN) has shown some very interesting options trading, and the trading looks to be a bet against all that huge volatility we have seen. Joe Kunkle of OptionsHawk.com noted: ITMN with a 2,000X4,000X2,000 contract butterfly call spreads at the March $25/$30/$35 strikes.  This trade bets on volatility to collapse, which will happen after the March 9th FDA meeting on it’s lung drug pirfenidone, given priority review for treating the chronic lung disease idiopathic pulmonary fibrosis, a disease impacting around 200,000 people in the US and Europe.  Lazard Capital feels there is more than a 50% chance the drug gets approved, and has a $25 target for shares.  However, the FDA may require post-approval studies for indications of effectiveness.  It also sees share... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3296734 Mon, 22 Feb 2010 17:25:55 +0100 3296734 http://www.medworm.com/index.php?rid=3293255&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FLxfHYYwFaNg%2Ftwo-key-analyst-call-in-biohealth-space-dndn-hgsi.html We have seen two very key biotech analyst calls this morning, and shares of both are responding.  Dendreon Corp. (NASDAQ: DNDN) and Human Genome Sciences (NASDAQ: HGSI) were both given positive brokerage initiations this morning. Dendreon Corp. (NASDAQ: DNDN) is seeing gains this morning after the stock was started as “Overweight” and $46 target at JPMorgan.  The call is based upon a belief that PROVENGE will be approved for advanced prostate cancer. This is actually not the highest price target as a $50 target does already exist, but this implies a 42% upside to the target price versus the $32.36 closing bell price on Friday.  Shares are up 2.6% before the open on this call. Human Genome Sciences (NASDAQ: HGSI) was resumed at “Buy” with a $35 price target at Bof... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3293255 Mon, 22 Feb 2010 13:25:13 +0100 3293255 http://www.medworm.com/index.php?rid=3289791&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FHNbkkBfQ1cE%2Fbuyout-rumors-resurface-in-biotech-maybe-dndn-mygn.html Sometimes it is the action seen in stock options gets traders moving more than the action in the stock.  With more commentators on CNBC and other media outlets talking about ‘elevated options trading seen in…’ it gets even more on alert.  From our best read today, that seems to be the case in Dendreon Corp. (NASDAQ: DNDN) and Myriad Genetics Inc. (NASDAQ: MYGN).  There has been talk of ‘buyout rumors’ but we would first and foremost stress ‘caveat emptor’ when it comes to this. Dendreon shares are up only 1.4% before the closing bell at $32.46 and not even on any crazy volume.  But there was a new high today of $32.62.  So far we have seen more than 18,000 CALLS and more than 6,000 PUTS trade today… but again, expiration may be part of t... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3289791 Fri, 19 Feb 2010 20:49:27 +0100 3289791 http://www.medworm.com/index.php?rid=3274577&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FKtBYH03tn1s%2Frigel-attacks-rheumatoid-arthritis-with-astrazeneca-rigl-azn.html Rigel Pharmaceuticals (NASDAQ: RIGL) may be the biotech winner this Tuesday.  The company has signed a pact with AstraZeneca (NYSE: AZN) which could ultimately bring in about $1.25 billion if all targets are met.  This pact is a licensing agreement for Rigel’s rheumatoid arthritis drug R788 or fostamatinib disodium. Rigel said last year that its R788 significantly improved rheumatoid arthritis symptoms in patients in a phase II study and Rigel has been seeking a development partner to help finance phase III studies. AstraZeneca will design a global phase III study for the RA drug and believes that the study will be initiated in the second half of this year.  We will double-check the goal dates here because the new drug application target date appears to be 2013 for the FDA and Eur... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3274577 Tue, 16 Feb 2010 13:20:03 +0100 3274577 http://www.medworm.com/index.php?rid=3265140&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F5y6t29tbbeQ%2Fdividends-coming-in-biotech-pharma-wcrx-amgn-mrk-pfe-pph-bbh.html Many investors have been focusing on the number of dividend raises we have so far seen since the end of December.  It is the perfect vote of confidence issued by a company, much more so than a share buyback plan.  The dividend means “we will be able to this rate over and over” for investors.  There have been very few big moves in the BioHealth arena.  We have two very interesting dividend candidates.  Amgen Inc. (NASDAQ: AMGN) as the world’s largest independent biotech stock, and Warner Chilcott plc (NASDAQ: WCRX) as perhaps the newest and best up and comer in the pharmaceuticals sector. Neither pay a dividend.  Not yet.  It would seem that the most likely candidate of the two would be Warner Chilcott because companies like Merck & Co. (NYSE: MRK) and Pfizer In... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3265140 Thu, 11 Feb 2010 17:36:05 +0100 3265140 http://www.medworm.com/index.php?rid=3249627&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FcVo16tIcmoA%2Fcell-therapeutics-facing-tougher-fda-ctic.html Cell Therapeutics, Inc. (NASDAQ: CTIC) is getting clipped on Pixantrone this morning.  The company was told by the FDA that there is limited clinical data on its proposed cancer drug, and that there were higher side effects and higher death incidents.  Unfortunately, this comes ahead of a panel review date that is set for Wednesday, February 10, 2010.  We have late April, on or about April 23, 2010, as the final decision date from the FDA for Pixantrone. Pixantrone is the company’s pending treatment of relapsed and refractory non-Hodgkin’s lymphoma, although this is indicated for those who have seen their disease progress after having received treatment with at least two other therapies. Cell Therapeutics had raised about $30 million in January via securities sales.  Pixant... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3249627 Mon, 08 Feb 2010 14:47:10 +0100 3249627 http://www.medworm.com/index.php?rid=3248112&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FR1wo2lqQZXs%2Fnew-restless-leg-syndrome-review-for-xenoport-xnpt-gsk.html XenoPort, Inc. (NASDAQ: XNPT) has a big day coming for its GSK1838262/XP13512 (gabapentin enacarbil) next week.  The company has a date of February 9 for an FDA Prescription Drug User Fee Act (PDUFA) decision on its Horizant. This is the dated  goal for the company’s New Drug Application for Horizant for the treatment of moderate-to-severe primary restless legs syndrome. Horizant is licensed to GlaxoSmithKline (NYSE: GSK) in the United States and several other countries. There is one concern here… The company’s release last week noted that the GaxoSmithKline partnership may be in doubt because Glaxo has noted that it may end research on depression and pain treatments.  GSK and XenoPort are discussing the next steps in the development plan for XP13512 in the neuropathic... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3248112 Sat, 06 Feb 2010 16:46:30 +0100 3248112 http://www.medworm.com/index.php?rid=3245806&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FsND3o1uFF0w%2Famag-fights-back-amag.html AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) has had a very tough week, whether it was a market with a bad trading tape or not.  The stock’s weakness was after an analyst from a relatively unknown firm called Summer Street downgraded the stock to Neutral from Buy over concerns that Feraheme patients are being hospitalized with severe allergic reaction events.  Shares were above $45.00 on Wednesday, yet the stock went as low as $35 today before word that a rebuttal was coming.  Then after the close, the company is out defending itself showing that the risks here are very low and may not be any different than previously thought. After the close of trading today, the maker of treatments for anemia and imaging agents provided a safety update on Feraheme®.  The company noted, “Sin... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3245806 Fri, 05 Feb 2010 21:39:51 +0100 3245806 http://www.medworm.com/index.php?rid=3241994&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FAc6GZgz34F0%2Fhuman-genome-when-insiders-sell-stock-hgsi.html Human Genome Sciences, Inc. (NASDAQ: HGSI) has been one of the great biotech success stories, with returns far dwarfing the 10-bagger or 1,000%.  This went from a small genomics company to a company with what seems to be or likely to be the newest lupus treatment in a generation after (and if) the FDA approves of it.  While management has been quick to quiet buyout rumors, the investment community for most of 2009 was betting or hoping that the company would be acquired. Yet when you see insiders making share sales, and some significant share sales, it probably makes you think no real deal is on the table.  In short, buying Human Genome Sciences here now better be for that pending FDA approval and for its pipeline rather than for a hope of a buyout.  Here were the insider sales we have... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3241994 Thu, 04 Feb 2010 18:46:07 +0100 3241994 http://www.medworm.com/index.php?rid=3229815&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fj9xa-nWCX6o%2F10-bagger-hunt-heads-back-to-repros-rprx.html Repros Therapeutics Inc. (NASDAQ: RPRX) is soaring in the quest for the next ten-bagger…. This is a micro-cap stock that had a $19.1 million market cap before this morning’s news.  The company reported that it has received verbal confirmation from the FDA’s Division of Metabolic and Endocrine Drug Products.  According to this, the company may initiate its Investigational New Drug Application for the study of oral Androxal as a potential treatment of hypogonadal men with Type II Diabetes with a Phase IIa trial.  While the move to chase the next 1,000% potential gainer is often on hype, it is at least easy to see why traders, speculators and investors would be chasing this stock. According to the press release, The FDA noted no clinical hold issues.  It did add that the... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3229815 Tue, 02 Feb 2010 14:30:00 +0100 3229815 http://www.medworm.com/index.php?rid=3229816&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FQXqgoMJkrhQ%2Fintermune-volatily-bets-through-the-roof-itmn.html We noted last week that there had been some extra options activity over in InterMune, Inc. (NASDAQ: ITMN) ahead of a date-review decision.   Today saw excess trading in the stock, and explosive trading volume in both the put and call options as traders made their volatility bets for a binary trading event scheduled for March 9.  The stock traded over 3.4 million shares versus 683,000 shares on average.  The stock closed up 5.7% at $16.50 and the 52-week trading range is $10.48 to $19.12.  We do not care about the FEB-2010 options as they are before the date, but MAR-2010 options expiration date is on March 19, 2010. CALL    Volume    OpInt  Last 15.00    1,755    5,074   $5.40 17.50    14,991    7,596  $4.50 20.00    8,065    2,863  $3.70 22.50    2,375... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3229816 Tue, 02 Feb 2010 01:50:48 +0100 3229816 http://www.medworm.com/index.php?rid=3226262&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FmFa1SmetRlg%2Fgenerex-files-to-raise-cash-gnbt.html You have seen us talk about companies in the BioHealth and biotech space after big pops of news lately.  But some companies are also just raising cash, or leaving room to raise cash if needed.  It is the second group that today’s filing from Generex Biotechnology Corp. (NASDAQ: GNBT) for up to $150 million falls into. What is interesting here is that this is effectively the same size of the company today.  Generex has a market cap after a 6.8% gain to $0.63 today of only about $156 million.  Its 52-week trading range is $0.08 to $1.14 and the average daily volume is only about 2.94 million shares. The company may or may not sell shares, because this filing is to replace an existing shelf registration: “The Registrant previously filed a Registration Statement on Form S-3 (... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226262 Fri, 29 Jan 2010 21:32:39 +0100 3226262 http://www.medworm.com/index.php?rid=3226263&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FJD1wwOBFfI8%2Fintermune-sees-pre-event-options-activity-itmn.html InterMune, Inc. (NASDAQ: ITMN) is up today despite the soft markets.  This would actually make this the third day of gains in a row.  The options trading continues to be very bullish, as shares gain 3% and implied volatility pops another 4% today.  There is options trading building up here as well. The Company recently raised cash through a 5 million share issuance.  It’s key drug pirfenidone was granted fast track status at the FDA in early January, 6 month review period.  It treats IPF, a fatal lung disease.  Data is expected in the first from Phase2b studies of RG7227 plus SOC, for HCV. Today there was a buyer of 2,500 March $17.50 calls at the offer on wide spreads, and now a 1,250 contract March $17.50/$15 bullish risk reversal trades for a 5 cent credit. On Wednesday impl... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226263 Fri, 29 Jan 2010 20:21:47 +0100 3226263 http://www.medworm.com/index.php?rid=3226264&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F4Ib55Qa3jMA%2Fgenvec-shows-again-the-risks-of-biotech-trophy-hunting-gnvc-rosg-mrna-cycc.html We have covered over and over in recent months about the news flow of biotech and emerging biohealth companies creating an avenue that is causing traders to chase many speculative stocks up exponentially on news.  In 2009 we had perhaps a dozen biotech and biohealth related stocks which posted gains of 1,000% or more, and this is where that term of a ‘ten-bagger’ comes from.  In recent weeks we have seen shares of GenVec Inc. (NASDAQ: GNVC) rise exponentially. The 52-week low is $0.33 and this was effectively at $1.05 to $1.20 at the very end of 2009.  In recent weeks and recent trading days we have seen news that allowed this to run even above $3.00.  Then today came the share price haircut after the company entered into a registered offering of $28 million in agreements w... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226264 Wed, 27 Jan 2010 18:08:17 +0100 3226264 http://www.medworm.com/index.php?rid=3226265&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FdwEc9K2twSs%2Fpfizer-outlines-new-drug-rd-pipeline-pfe-mrk-nvs-gsk.html Pfizer Inc. (NYSE: PFE) is making a pipeline presentation today, and it is meant to address a serious and potentially severe issue affecting all Big Pharma companies from Merck & Co. (NYSE: MRK) after its Schering-Plough deal all the way down to where drug companies become biotech companies:  That is the billions and billions of dollars that may disappear from profits as key drug patents expire in the coming years.  This is also affecting Roche and companies like Novartis AG (NYSE: NVS) and GlaxoSmithKline plc (NYSE: GSK) on an international basis, which is why you have seen them make their own partnerships and acquisitions where possible. Pfizer is giving a pipeline update showing its own efforts to address a whole new class of potential blockbuster drugs in the years ahead.  Today... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226265 Wed, 27 Jan 2010 17:32:40 +0100 3226265 http://www.medworm.com/index.php?rid=3226266&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FxW8YZhaf9xk%2Fnew-fda-approval-in-diabetes-drug-nvo.html The FDA has announced the approval of Victoza made and marketed by Novo Nordisk (NYSE: NVO).  The approval is listed as being an approval to treat type-2 diabetes in come adults.  This has been a pending approval and is Novo Nordisk’s once-daily injection.  The drug is intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines; but it is not recommended as an initial therapy in patients who have not achieved adequate diabetes control on diet and exercise alone. Victoza is in a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists that help the pancreas make more insulin after eating a meal, and this was part of our own “Next $180 Billion in Drug Opportunities” from last year. The company has noted ... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226266 Mon, 25 Jan 2010 23:53:35 +0100 3226266 http://www.medworm.com/index.php?rid=3226267&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FeBne4-vrpaw%2Famgen-earnings-the-coin-toss-continues-amgn.html Amgen (NASDAQ: AMGN) has just reported earnings that appear disappointing on the surface.  The world’s largest independent biotech stock posted $1.05 EPS on revenue of $3.81 billion.  Unfortunately, Thomson Reuters estimates were $1.12 EPS and $3.85 billion.  The net number after backing out non-GAAP items was $0.92 EPS. The company is issuing its 2010 guidance of $5.05 to $5.25 EPS on revenues of $15.1 to $15.5 billion.  We have estimates of $5.12 EPS and $15.31 billion in revenues from Thomson Reuters. The company had already given guidance earlier this month at the JPMorgan Healthcare Conference, and this is not significantly out of line nor significantly concerning considering its recent path. Epogen sales were up 9% to $703 million, which was deemed as being above estimate... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226267 Mon, 25 Jan 2010 21:25:30 +0100 3226267 http://www.medworm.com/index.php?rid=3226268&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FNFubJijjNB0%2Ftrophy-hunting-no-yawns-over-somaxon-insomnia-drug-somx.html Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) has soared in after-hours trading as we have noted over and over how micro-cap and low-priced biotech stocks are seeing trophy hunters trying to find the next 1,000% move… That is the quest for the ten-bagger in investor slang.  The company provided an update on the status of its New Drug Application for Silenor for the treatment of insomnia.  It held a meeting with senior leadership at the FDA on January 20, 2010 to discuss the issues raised in the FDA’s Complete Response Letter Somaxon from December 2009. According to Somaxon, the FDA acknowledged that this resubmission would be considered a complete response and noted that no additional safety or efficacy data was needed.  Furthermore, the company now sees a decision from the F... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226268 Thu, 21 Jan 2010 23:35:55 +0100 3226268 http://www.medworm.com/index.php?rid=3226269&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FVnjJBCGpxfQ%2Flexicon-rejoins-diabetes-war-lxrx.html Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) is the beneficiary of data on the war against diabetes.  We might call this the rejoining in the war against diabetes,  but the term ‘rejoining’ would pertain just to its stock getting back in the news.  ‘We have addressed over and over how the trading and investing community has been seeking the 1,000% returns or the ten-baggers on many occasions.  Today is not really a ten-bagger or trophy hunting example if you look at the reaction and trading action, although this probably did get a secondary benefit from the interest in low-priced biotechs. Today’s news is based upon a successful second trial of the company’s diabetes treatment drug candidate.  The company was studying the performance of its LX4211 drug in ... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226269 Wed, 20 Jan 2010 20:28:59 +0100 3226269 http://www.medworm.com/index.php?rid=3226270&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2Fl85xAu2Ebp0%2Fsequenom-close-to-getting-off-maybe-scott-free-sqnm.html Sequenom, Inc. (NASDAQ: SQNM) may be pulling the oldest hat trick in the book.  It is settling a class action suit.  This always sounds good on the surface, except for the notion that these class action settlements can sometimes exonerate a company from future liabilities.  The good news here is that there is an opt-out provision.  The bad news is that it might not matter. The SEC filing stated: On January 15, 2010, Sequenom, Inc. announced entry into a stipulation of settlement which will resolve the class action securities lawsuits consolidated under the caption In re Sequenom, Inc. Securities Litigation, S.D. Cal. Case No. 09-CV-0921 LAB (WMc), pending in the U.S. District Court for the Southern District of California. Attorneys for Harry Stylli, Paul Hawran, Allan T. Bombard, Charl... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226270 Fri, 15 Jan 2010 13:44:17 +0100 3226270 http://www.medworm.com/index.php?rid=3226271&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2FGZceA-0gh4g%2Fis-enzon-a-real-real-takeover-target-again-enzn-pfe.html Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) is not your normal biotech and emerging pharma company.  It is a name that has been tossed around in the rumor mill in the past, and that is the case this week.  That is part of why the stock is at 52-week highs today.  Pfizer Inc. (NYSE: PFE) is the rumored buyer this time around, although other companies have been rumored on and off in the past.  While it is an $11+ stock today, this stock used to trade at an exponential share price and it has nearly a 20-year history as a public company now. What makes this an interesting ‘buyout story’ is that Enzon already has a special meeting on deck on Wednesday, January 27, 2010, as the date of its special shareholder meeting to vote on the proposed sale of its specialty pharmaceutical bus... BioHealth Investor info http://www.medworm.com/rss/comments.php?id=3226271 Thu, 14 Jan 2010 20:27:17 +0100 3226271 http://www.medworm.com/index.php?rid=1411845&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F281084115%2Fsms-makes-its-way-into-us-health-care.html by David E. Williams Health Business Blog Text messaging isn’t exactly big news. Most people have heard about it, even if they associate it only with teens who’ve given up talking on the phone or even meeting in person in order to spend their... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1411845 Thu, 17 Apr 2008 12:32:00 +0100 1411845 http://www.medworm.com/index.php?rid=1411846&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F281084116%2Fnatus-further-consolidates-us-newborn.html by Doug Cress Med Tech Sentinel Natus Medical (BABY) announced yesterday that it will acquire SonaMed, a privately held company based in Waltham, MA. SonaMed manufactures and markets the Clarity Screener for the screening of hearing loss in... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1411846 Thu, 17 Apr 2008 12:25:00 +0100 1411846 http://www.medworm.com/index.php?rid=1370862&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F270222667%2Fbiohealth-investorcom-is-for-sale.html I was dreading this announcement, but its time has come. My career as a dentist is finally taking off and keeping me too busy to maintain this blog's full potential. Therefore, after a year and a half of surprising success I have no choice but to... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1370862 Mon, 14 Apr 2008 19:56:00 +0100 1370862 http://www.medworm.com/index.php?rid=1367988&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F268642562%2Ffridays-top-medical-biotech-stocks_11.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PDL BIOPHARMA INC [PDLI] +16.91% SENESCO TECH [SNT] +10.40% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1367988 Fri, 11 Apr 2008 22:03:00 +0100 1367988 http://www.medworm.com/index.php?rid=1363852&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F267940596%2Fto-antigenics-or-not-to-antigenics.html by Michael Shulman BiotechBlitz Antigenics (AGEN) got a Russian approval for its cancer immunotherapy -- a cancer "vaccine" is the sexy, headline grabbing term. This also created a few seconds of buzz around two other immunotherapy companies,... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1363852 Thu, 10 Apr 2008 20:25:00 +0100 1363852 http://www.medworm.com/index.php?rid=1363853&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F267940598%2Fthursdays-top-medical-biotech-stocks_10.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology GENETIC TECH SPON [GENE] +18.21% TRUBION PHARMACEUTIC [TRBN] +15.83%... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1363853 Thu, 10 Apr 2008 20:18:00 +0100 1363853 http://www.medworm.com/index.php?rid=1361142&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F267274819%2Faida-pharma-affiliate-developing-new.html by Richard Daverman, PhD ChinaBio Today Aida Pharmaceuticals, Inc. (OTCBB: AIDA) is working on a new wide-spectrum antibiotic that was discovered by its recently acquired affiliate, the Jiangsu Institute of Microbiology Co., Ltd (JSIM).... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1361142 Wed, 09 Apr 2008 21:30:00 +0100 1361142 http://www.medworm.com/index.php?rid=1361143&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F267274820%2Fwednesdays-top-medical-biotech-stocks_09.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PROTEO INC [PTEO.OB] +31.19% CHAMPIONS BIOTECHNLG [CSBR.OB] +9.52% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1361143 Wed, 09 Apr 2008 21:23:00 +0100 1361143 http://www.medworm.com/index.php?rid=1358621&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F266654579%2Fdrug-recycling-not-much-of-solution.html by David E. Williams Health Business Blog The Associated Press reports that most US states have implemented “drug recycling” programs or are considering doing so. The basic idea is to accept donations of unused drugs and re-dispense them to... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1358621 Tue, 08 Apr 2008 23:12:00 +0100 1358621 http://www.medworm.com/index.php?rid=1358622&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F266654580%2Ftuesdays-top-medical-biotech-stocks_08.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ANTIGENICS INC [AGEN] +22.67% ADVANCED LIFE SCIENC [ADLS] +16.68% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1358622 Tue, 08 Apr 2008 23:05:00 +0100 1358622 http://www.medworm.com/index.php?rid=1356364&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F265919079%2Fnanogen-strengthens-active-partnering.html by Doug Cress Med Tech Sentinel Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to the Research Market As the biomedical industry works to gain a better understanding of the molecular basis of disease, the... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1356364 Mon, 07 Apr 2008 21:35:00 +0100 1356364 http://www.medworm.com/index.php?rid=1356365&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F265919080%2Fmondays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PLURISTEM THERAPEUTC [PSTI] +107.90% TRANSDEL PHARMACTL [TDLP.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1356365 Mon, 07 Apr 2008 21:24:00 +0100 1356365 http://www.medworm.com/index.php?rid=1352280&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F264213725%2Fno-recession-in-healthcare.html by David E. Williams Health Business Blog The housing market’s in a tailspin, gas and food prices are crazy and the “R” word is in the air. Retailers are seeing a drop in business and more people are taking public transportation. But you... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1352280 Fri, 04 Apr 2008 20:53:00 +0100 1352280 http://www.medworm.com/index.php?rid=1352281&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F264206264%2Ffridays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology XENACARE HOLDINGS [XCHO.OB] +28.71% OPEXA THERAPEUTICS [OPXA] +27.83% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1352281 Fri, 04 Apr 2008 20:46:00 +0100 1352281 http://www.medworm.com/index.php?rid=1349847&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F263585855%2Fbiotech-turnaround.html by Michael Shulman BiotechBlitz Are biotech's turning around? They are certainly beating the market and, frankly, worrying about FDA decisions is easier now than worrying about how much toxic waste is hidden on a bank's balance sheet. I have a... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1349847 Thu, 03 Apr 2008 21:28:00 +0100 1349847 http://www.medworm.com/index.php?rid=1349848&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F263585859%2Fthursdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IDM PHARMA INC [IDMI] +15.37% ADVANCED LIFE SCIENC [ADLS] +14.69% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1349848 Thu, 03 Apr 2008 21:21:00 +0100 1349848 http://www.medworm.com/index.php?rid=1346242&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F262913773%2Fchina-biopharma-stocks-suffer-tough.html by Richard Daverman, PhD ChinaBio Today China biopharma stocks listed on US exchanges weathered a difficult first quarter of 2008. The ChinaBio® Stock Index fell from 1675 to 1215 during the three months, a substantial decline of 27.4%. During... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1346242 Wed, 02 Apr 2008 21:13:00 +0100 1346242 http://www.medworm.com/index.php?rid=1346243&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F262913774%2Fwednesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PROTEO INC [PTEO.OB] +34.58% AETERNA ZENTARIS [AEZS] +32.46% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1346243 Wed, 02 Apr 2008 21:05:00 +0100 1346243 http://www.medworm.com/index.php?rid=1344604&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F262707981%2Fnovare-surgical-removes-appendix-via.html by Doug Cress Med Tech Sentinel Sorry guys, we’re out of luck. Novare Surgical Systems announced today the successful completion of an appendix removal performed using its RealHand HD instruments. Two surgeons from the UC San Diego Medical... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1344604 Wed, 02 Apr 2008 14:38:00 +0100 1344604 http://www.medworm.com/index.php?rid=1344605&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F262263266%2Ftuesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology CELL GENESYS INC [CEGE] +31.49% IDENIX PHARMACEUT [IDIX] +20.32% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1344605 Tue, 01 Apr 2008 22:38:00 +0100 1344605 http://www.medworm.com/index.php?rid=1340914&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F261532319%2Fmondays-top-medical-biotech-stocks_31.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology TRANSDEL PHARMACTL [TDLP.OB] +17.45% BIOCRYST PHARM INC [BCRX]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1340914 Mon, 31 Mar 2008 21:23:00 +0100 1340914 http://www.medworm.com/index.php?rid=1337083&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F260884812%2Fcephalon-new-player-in-chronic.html by Hisham S. Ayoub, DMD BioHealth Investor For the first time in seven years a new therapy for Chronic Lymphocytic Leukemia (CLL) has been cleared in the U.S. by the FDA. Biotech firm Cephalon’s (CEPH) TREANDA (bendamustine hydrochloride) was... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1337083 Sun, 30 Mar 2008 19:58:00 +0100 1337083 http://www.medworm.com/index.php?rid=1335361&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F259992866%2Ffda-and-overseas-drug-approvals.html by Mark Senak Eye On FDA Where is the Most Promising Pipeline? For a while now, I've been thinking about the growing number of drugs that are being approved overseas and going on the market overseas, but are not getting approved or are getting... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1335361 Sat, 29 Mar 2008 02:03:00 +0100 1335361 http://www.medworm.com/index.php?rid=1334567&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F259878206%2Ffridays-top-medical-biotech-stocks_28.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PROTEO INC [PTEO.OB] +93.07% BIOSANTE PHARMA INC [BPAX] +19.39% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1334567 Fri, 28 Mar 2008 21:29:00 +0100 1334567 http://www.medworm.com/index.php?rid=1332719&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F259367481%2Fdrugs-penny-wise-but-pound-foolish.html by Michael Shulman BiotechBlitz I typically write about stocks of interest to investors, but today I am just hacked off. Bear with me and pardon the pun. Not all drugs and biotech companies are created equal -- and the belief that a drug may... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1332719 Fri, 28 Mar 2008 02:17:00 +0100 1332719 http://www.medworm.com/index.php?rid=1332720&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F259332096%2Fthursdays-top-medical-biotech-stocks_27.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IMMUNOSYN CORPORATIN [IMYN.OB] +19.90% BIOSANTE PHARMA INC [BPAX]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1332720 Fri, 28 Mar 2008 00:42:00 +0100 1332720 http://www.medworm.com/index.php?rid=1317898&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F255206908%2Fpainting-colon-early-stage-cancer.html by Doug Cress Med Tech Sentinel Most cases of colon cancer begin as small noncancerous polyps. Over time these polyps may become colon cancers. Regular screening helps identify polyps before they become cancerous, allowing for prophylactic... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1317898 Thu, 20 Mar 2008 23:32:00 +0100 1317898 http://www.medworm.com/index.php?rid=1317899&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F255206909%2Fthursdays-top-medical-biotech-stocks_20.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IOMAI CORPORATION [IOMI] +27.62% TRUBION PHARMACEUTIC [TRBN] +22.18%... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1317899 Thu, 20 Mar 2008 23:26:00 +0100 1317899 http://www.medworm.com/index.php?rid=1316791&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F254905950%2Famgen-whither-thou-goest.html by Michael Shulman BiotechBlitz I have disliked Amgen (AMGN) for a very long time and have the good fortune of having two publishing platforms to discuss the company: my ChangeWave Biotech Investor service and my short service, ChangeWave... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1316791 Thu, 20 Mar 2008 12:59:00 +0100 1316791 http://www.medworm.com/index.php?rid=1315435&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F254542902%2Fwednesday-recap-biotech-restructuring.html by H.S. Ayoub, DMD BioHealth Investor Nasdaq Biotechnology Index (^NBI) -2.92% Amex Pharmaceutical Index (^DRG) -2.69% iShares Dow Jones Medical Devices (IHI) -1.25% Kosan Biosciences (KOSN) up 24.34%... investors were cheering the company's... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1315435 Wed, 19 Mar 2008 21:18:00 +0100 1315435 http://www.medworm.com/index.php?rid=1315436&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F254514735%2Fwednesdays-top-medical-biotech-stocks_19.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology KOSAN BIOSCIENCES [KOSN] +24.34% HALOZYME THERAPEUTIC [HALO] +23.17%... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1315436 Wed, 19 Mar 2008 20:54:00 +0100 1315436 http://www.medworm.com/index.php?rid=1312481&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F254039305%2Fanother-silly-bio-generics-bill.html by David E. Williams Health Business Blog Two Congressional Reps have introduced a bill to create a pathway for generic biopharmaceuticals. It seems to me like a big waste of time. The bill has the following key provisions, according to Kaiser... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1312481 Wed, 19 Mar 2008 03:32:00 +0100 1312481 http://www.medworm.com/index.php?rid=1312482&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253928985%2Ftuesday-recap-medical-biotech-stocks.html by H.S. Ayoub, DMD BioHealth Investor Nasdaq Biotechnology Index (^NBI) +2.85% Amex Pharmaceutical Index (^DRG) +2.30% iShares Dow Jones Medical Devices (IHI) +3.03% Ista Therapeutics (ISTA) up 39.10%... Well, I guess the company's... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1312482 Tue, 18 Mar 2008 22:42:00 +0100 1312482 http://www.medworm.com/index.php?rid=1312483&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253890674%2Fchina-priority-for-astrazeneca.html by Richad Daverman, PhD ChinaBio Today Expanding the presence of AstraZeneca (NYSE: AZN) in the Asia-Pacific region in general and China specifically is a priority for AstraZeneca, according to John Ramsey, AstraZeneca’s Vice President for... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1312483 Tue, 18 Mar 2008 21:55:00 +0100 1312483 http://www.medworm.com/index.php?rid=1312484&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253890675%2Ftuesdays-top-medical-biotech-stocks_18.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology SUNESIS PHARMACEUTIC [SNSS] +31.58% DARA BIOSCIENCES [DARA] +24.56% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1312484 Tue, 18 Mar 2008 21:42:00 +0100 1312484 http://www.medworm.com/index.php?rid=1309130&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253346626%2Fdespite-media-carping-americans-largely.html by Nathan Burchfiel Business & Media Institute Media attacks on pharmaceutical companies don't resonate with the public, which overwhelmingly believes drug makers improve quality of life. Seven out of ten Americans believe prescription drugs... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1309130 Tue, 18 Mar 2008 01:02:00 +0100 1309130 http://www.medworm.com/index.php?rid=1309131&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253245449%2Fmonday-quickie-medical-biotech-stocks.html by H.S. Ayoub, DMD BioHealth Investor QLT Inc. (QLTI) up 41.63%... The FDA has completed its review the company's labeling supplement (sNDA) for Aczone(TM) and has removed certain requirements imposed earlier. Aczone is the only acne treatment... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1309131 Mon, 17 Mar 2008 20:44:00 +0100 1309131 http://www.medworm.com/index.php?rid=1307870&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F253216103%2Fmondays-top-medical-biotech-stocks_17.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology QLT INC [QLTI] +41.63% TRUBION PHARMACEUTIC [TRBN] +18.55% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1307870 Mon, 17 Mar 2008 20:24:00 +0100 1307870 http://www.medworm.com/index.php?rid=1306587&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F252753698%2Fjp-morgan-grabs-bear-stearns-for-2-long.html by H.S. Ayoub, DMD BioHealth Investor I know this is supposed to be a blog covering the biotechnology and medical industry, but in an unprecedented move for this blog, a major non-health related event will have to be commented on. Bear Steans... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1306587 Mon, 17 Mar 2008 02:59:00 +0100 1306587 http://www.medworm.com/index.php?rid=1306588&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F252748372%2Fhacking-heart.html by Doug Cress Med Tech Sentinel A team of computer security researchers have remotely hacked Medtronic’s (MDT) Maximo – a stopwatch-sized implantable cardiac defibrillator. Armed with an antenna, radio hardware and a PC, the team was able to... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1306588 Mon, 17 Mar 2008 02:52:00 +0100 1306588 http://www.medworm.com/index.php?rid=1305017&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F251643196%2Ffridays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology SGX PHARMACEUTICALS [SGXP] +16.28% REXAHN PHARMACEUTICL [RXHN.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1305017 Fri, 14 Mar 2008 21:25:00 +0100 1305017 http://www.medworm.com/index.php?rid=1301891&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F251032157%2Fpharma-sales-slowdown.html by Mark S. Senak Eye On FDA IMS, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries released the annual "U.S. Pharmaceutical Market Performance Review" which found that pharmaceutical market... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1301891 Thu, 13 Mar 2008 22:37:00 +0100 1301891 http://www.medworm.com/index.php?rid=1301892&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F251005363%2Fthursdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology DARA BIOSCIENCES [DARA] +23.75% SUNESIS PHARMACEUTIC [SNSS] +11.35%... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1301892 Thu, 13 Mar 2008 21:11:00 +0100 1301892 http://www.medworm.com/index.php?rid=1298814&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F250347376%2Fwednesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology THIRD WAVE TECH IN [TWTI] +31.27% IMMUNOGEN INC [IMGN] +19.29% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1298814 Wed, 12 Mar 2008 20:25:00 +0100 1298814 http://www.medworm.com/index.php?rid=1297930&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F250128326%2Fcepheid-false-hit-from-false-claim.html by Michael Shulman BiotechBlitz Before you read this, please know I do not own this stock. I do recommend it in my service. I am writing this because a hatchet job has been done on a product category that can save tens of thousands of lives and... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1297930 Wed, 12 Mar 2008 12:27:00 +0100 1297930 http://www.medworm.com/index.php?rid=1296170&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F249734191%2Ftuesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology REXAHN PHARMACEUTICL [RXHN.OB] +25.00% TRUBION PHARMACEUTIC [TRBN]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1296170 Tue, 11 Mar 2008 20:41:00 +0100 1296170 http://www.medworm.com/index.php?rid=1294720&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F249630015%2Fanavex-life-sciences-takes-innovative.html Anavex Life Sciences (AVLX.OB) BHI Company Directory Biopharmaceutical company takes its cues from new FDA standards When it comes to creating drugs to combat the world’s most devastating diseases, established pharmaceutical companies... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1294720 Tue, 11 Mar 2008 17:13:00 +0100 1294720 http://www.medworm.com/index.php?rid=1292351&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F249107966%2Fmondays-top-medical-biotech-stocks_10.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology TONGJITANG CH MD ADR [TCM] +31.37% TRANSDEL PHARMACTL [TDLP.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1292351 Mon, 10 Mar 2008 21:06:00 +0100 1292351 http://www.medworm.com/index.php?rid=1286441&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F247397335%2Fairborne-justice.html by Doug Cress Med Tech Sentinel Airborne is a dietary supplement and health formula which is said to help ward off harmful bacteria and germs, and help prevent the flu and the common cold. The formula contains herbal extracts, amino acids,... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1286441 Fri, 07 Mar 2008 13:56:00 +0100 1286441 http://www.medworm.com/index.php?rid=1276107&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F245102747%2Fmondays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology HESKA CORPORATION [HSKA] +22.30% EURAND N.V. [EURX] +14.18% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1276107 Mon, 03 Mar 2008 21:40:00 +0100 1276107 http://www.medworm.com/index.php?rid=1274962&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F244872275%2Fbehind-great-wall-of-china-biotech.html by Greg Scott ChinaBio Today Editor's note: The following is an edited excerpt combining questions from interviews with our Executive Editor, Greg Scott, who is also President of ChinaBio® LLC, conducted by CCTV in Beijing, and Windhover... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1274962 Mon, 03 Mar 2008 14:09:00 +0100 1274962 http://www.medworm.com/index.php?rid=1274963&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F244872276%2Fexpanded-indications-for-immunicons.html by Doug Cress Med Tech Sentinel Immunicon’s (IMMC) CellSearch Circulating Tumor Cell (CTC) Kit has received FDA clearance as an aid in the monitoring of patients with metastatic prostate cancer. The kit is now cleared for three of the four most... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1274963 Mon, 03 Mar 2008 14:04:00 +0100 1274963 http://www.medworm.com/index.php?rid=1269673&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F243564519%2Ffridays-top-medical-biotech-stocks_29.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology MOMENTA PHARMA [MNTA] +28.61% TRANSDEL PHARMACTL [TDLP.OB] +23.33% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1269673 Fri, 29 Feb 2008 21:53:00 +0100 1269673 http://www.medworm.com/index.php?rid=1268590&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F243307637%2Freplidyne-announces-year-end-results.html by Adam Rubenstein CLSDF IMHO I remain incredibly optimistic about Replidyne’s (NASDAQ: RDYN), a leader in next-generation anti-infective products, direction (note: this in no why should be interpreted as investment advice). After being dealt a... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1268590 Fri, 29 Feb 2008 12:54:00 +0100 1268590 http://www.medworm.com/index.php?rid=1266664&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F242946477%2Fthursdays-top-medical-biotech-stocks_28.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology TRANSDEL PHARMACTL [TDLP.OB] +25.00% OCTILLION CORP NEW [OCTL.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1266664 Thu, 28 Feb 2008 21:26:00 +0100 1266664 http://www.medworm.com/index.php?rid=1265291&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F242754606%2F20-surprising-ways-wal-mart-clinics.html By Jessica Hupp RNCentral Big-box behemoth Wal-Mart has ventured into the healthcare realm, offering low-cost, walk-in clinics in more and more of its stores every day. Although Wal-Mart medicine may not sound like a great idea at first, these... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1265291 Thu, 28 Feb 2008 14:36:00 +0100 1265291 http://www.medworm.com/index.php?rid=1263511&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F242345006%2Fwednesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology VION PHARM INC [VIOND] +17.33% SEQUENOM INC [SQNM] +9.14% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1263511 Wed, 27 Feb 2008 21:22:00 +0100 1263511 http://www.medworm.com/index.php?rid=1261804&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F242213653%2Ffda-strategy-when-under-attack-drift.html by Mark S. Senak Eye On FDA In recent weeks, policymakers have turned up the heat on the FDA. First, Congressman Bart Stupak (D-MI) sent Dr. Andrew C. von Eschenbach a Valentine by demanding his resignation on February 14. Less than a week... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1261804 Wed, 27 Feb 2008 17:19:00 +0100 1261804 http://www.medworm.com/index.php?rid=1261805&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F242213665%2Fprana-biotechnology-challenge-for-fda.html by Michael Shulman BiotechBlitz Prana Biotechnology (PRAN), a tiny Australian company working for many years on a treatment for Alzheimer's disease (AD), announced Phase II trial results yesterday that the company characterized as successful --... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1261805 Wed, 27 Feb 2008 17:15:00 +0100 1261805 http://www.medworm.com/index.php?rid=1260034&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F241744585%2Ftuesdays-top-medical-biotech-stocks_26.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IMMUNOSYN CORPORATIN [IMYN.OB] +23.91% BARRIER THERAPEUTICS [BTRX]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1260034 Tue, 26 Feb 2008 21:58:00 +0100 1260034 http://www.medworm.com/index.php?rid=1256357&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F241148620%2Fmondays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology GTX, INC. [GTXI] +36.46% NASTECH PHARM CO [NSTK] +35.64% GENAERA... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1256357 Mon, 25 Feb 2008 22:36:00 +0100 1256357 http://www.medworm.com/index.php?rid=1251172&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F239637038%2Ffridays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ONCOTHYREON [ONTY] +14.46% NOVAVAX INC [NVAX] +9.75% BARRIER... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1251172 Fri, 22 Feb 2008 21:22:00 +0100 1251172 http://www.medworm.com/index.php?rid=1250422&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F239369270%2Fis-off-label-promotion-off-mark.html by Karen Donovan Health Business Blog Most people know that off-label use of drugs is rampant, but not everyone may know its extent or history. In the WSJ article U.S. FDA gives boost to off-label drug use, the authors discuss the proposed FDA... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1250422 Fri, 22 Feb 2008 12:04:00 +0100 1250422 http://www.medworm.com/index.php?rid=1248991&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F239123970%2Fthursdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PLURISTEM THERAPEUTC [PSTI] +19.83% GTX, INC. [GTXI] +13.90% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1248991 Fri, 22 Feb 2008 00:50:00 +0100 1248991 http://www.medworm.com/index.php?rid=1246697&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F238544659%2Fbioms-medical-time-to-take-look.html by Michael Shulman BiotechBlitz A couple of weeks back Eli Lilly (LLY) cut what seemed to be a very good deal with a Canadian company, BioMS (MS.TO) for rights to its multiple sclerosis (MS) drug in trial, MBP8298. Catchy name, eh? The stock did... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1246697 Thu, 21 Feb 2008 03:27:00 +0100 1246697 http://www.medworm.com/index.php?rid=1246698&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F238411267%2Ftuesdays-top-medical-biotech-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ENCYSIVE PHARMA [ENCY] +110.19% NORTHWEST BIOTH NEW [NWBO.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1246698 Wed, 20 Feb 2008 21:24:00 +0100 1246698 http://www.medworm.com/index.php?rid=1243529&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F237970623%2Fnew-public-relations-and-public-affairs.html by Mark S. Senak Eye On FDA Last evening, CBS 60 Minutes ran an investigative report rather dramatically entitled "One Thousand Lives a Month" about the drug Trasylol, manufactured by Bayer for the control of bleeding in patients undergoing... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1243529 Wed, 20 Feb 2008 04:27:00 +0100 1243529 http://www.medworm.com/index.php?rid=1243530&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F237843252%2Ftueadays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology CELL GENESYS INC [CEGE] +19.92% ARTES MEDICAL, INC. [ARTE] +11.44% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1243530 Tue, 19 Feb 2008 23:09:00 +0100 1243530 http://www.medworm.com/index.php?rid=1236365&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F235778044%2Ffridays-top-biotech-medical-stocks_15.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology CELL GENESYS INC [CEGE] +19.80% ONCOTHYREON [ONTY] +12.65% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1236365 Fri, 15 Feb 2008 21:29:00 +0100 1236365 http://www.medworm.com/index.php?rid=1233326&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F235334431%2Fbaxters-heparin-problems-may-have-china.html by Richard Daverman, PhD ChinaBio Today Baxter’s (NYSE: BAX) heparin product, lately in the news because of recent side-effect problems, sourced its active pharmaceutical ingredient from a US supplier who, in turn, manufactured the drug in a... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1233326 Fri, 15 Feb 2008 03:53:00 +0100 1233326 http://www.medworm.com/index.php?rid=1233327&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F235184106%2Fthursdays-top-biotech-medical-stocks_14.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IDM PHARMA INC [IDMI] +37.67% ONCOTHYREON [ONTY] +18.68% IMMUNOSYN... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1233327 Thu, 14 Feb 2008 21:31:00 +0100 1233327 http://www.medworm.com/index.php?rid=1230418&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F234740641%2Ffind-and-treat-coronary-artery-disease.html by Doug Cress Med Tech Sentinel Bayer Healthcare (BAY.DE) affiliate Medrad and Minneapolis, MN-based Possis Medical (POSS) have entered into a definitive merger agreement whereby Medrad will acquire Possis for $19.50 a share, or $361... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1230418 Thu, 14 Feb 2008 03:46:00 +0100 1230418 http://www.medworm.com/index.php?rid=1230419&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F234591369%2Fwendesdays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology RENOVIS INC [RNVS] +18.18% CHAMPIONS BIOTECHNLG [CSBR.OB] +16.36% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1230419 Wed, 13 Feb 2008 21:21:00 +0100 1230419 http://www.medworm.com/index.php?rid=1226841&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F234129194%2Ffourth-quarter-2008-fda-warning-letters.html by Mark S. Senak Eye On FDA The pathetic rate of enforcement by CDER continues. I am so stymied why some smart reporter hasn't posed the question - what is happening when the amount of PDUFA dollars and money in the federal budget for FDA goes... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1226841 Wed, 13 Feb 2008 03:40:00 +0100 1226841 http://www.medworm.com/index.php?rid=1225625&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F233976435%2Ftuesdays-top-biotech-medical-stocks_12.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology DYAX CORP [DYAX] +20.79% ONCOTHYREON [ONTY] +12.12% ZIOPHARM... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1225625 Tue, 12 Feb 2008 21:35:00 +0100 1225625 http://www.medworm.com/index.php?rid=1223810&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F233498881%2Fcloser-look-at-accuray.html by Michael Shulman BiotechBlitz If enough people ask you a question, you should go out and find the answer. A few days ago I finished giving seminars at the Money Show in Orlando and four people asked me about a company I do not follow or... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1223810 Tue, 12 Feb 2008 02:39:00 +0100 1223810 http://www.medworm.com/index.php?rid=1223811&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F233403680%2Fmondays-top-biotech-medical-stocks_11.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IDM PHARMA INC [IDMI] +19.05% NORTHWEST BIOTH NEW [NWBO.OB] +16.84% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1223811 Mon, 11 Feb 2008 22:33:00 +0100 1223811 http://www.medworm.com/index.php?rid=1221343&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F232850160%2Fallergan-plunge-on-fda-review.html by H.S. Ayoub, DMD BioHealth Investor Shares of Allergan (AGN) plunged almost 6% on Friday following an announcement by the FDA that the agency launched a safety review of the company's flagship product, BOTOX, and Solstice Neuroscience's... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1221343 Sun, 10 Feb 2008 23:45:00 +0100 1221343 http://www.medworm.com/index.php?rid=1219523&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F231849213%2Ffridays-top-biotech-medical-stocks_08.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ARTES MEDICAL, INC. [ARTE] +17.26% IMMUNOSYN CORPORATIN [IMYN.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1219523 Fri, 08 Feb 2008 21:22:00 +0100 1219523 http://www.medworm.com/index.php?rid=1218227&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F231576102%2Fjuvaris-biotherapeutics-colorado-roots.html by Adam Rubenstein CLSDF For those of you who do not know…Steven Dow, DVM, Ph.D., is the Founder and Chief Scientific Advisor of Juvaris Biotherapeutics. Dr. Dow currently serves as Associate Professor in the Departments of Clinical Sciences and... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1218227 Fri, 08 Feb 2008 12:17:00 +0100 1218227 http://www.medworm.com/index.php?rid=1216572&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F231282650%2Fchina-shenghuo-to-bring-tcm-based.html by Richard Daverman, PhD ChinaBio Today China Shenghuo Pharmaceutical Holdings, Inc. (KUN) will begin marketing its new 12Ways® Skin Care products in the US during Q1 of 2008 on the Home Shopping TV Network. China Shenghuo introduced the... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1216572 Thu, 07 Feb 2008 23:51:00 +0100 1216572 http://www.medworm.com/index.php?rid=1216573&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F231268622%2Fthursdays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology OCTILLION CORP NEW [OCTL.OB] +15.11% MEDICINOVA, INC. [MNOV]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1216573 Thu, 07 Feb 2008 23:38:00 +0100 1216573 http://www.medworm.com/index.php?rid=1213354&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F230660267%2Ffda-needs-help.html by Mark S. Senak Eye On FDA Yesterday, February 3, 2007, the New York Times ran an editorial regarding the FDA. It was a decent piece that referred to the fact that is apparently just dawning on some that agency is woefully understaffed and... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1213354 Thu, 07 Feb 2008 01:50:00 +0100 1213354 http://www.medworm.com/index.php?rid=1213355&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F230580112%2Fwednesdays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology PIPEX PHARMACEUTALS [PP] +12.50% GENAERA CORP [GENR] +12.35% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1213355 Wed, 06 Feb 2008 22:52:00 +0100 1213355 http://www.medworm.com/index.php?rid=1208089&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F230063816%2Fidm-pharma-jumps-234-after-big.html by H.S. Ayoub, DMD BioHealth Investor In what might be the greatest coincidence in Wall Street history IDM Pharma (IDMI) stock skyrocketed by 234% on Tuesday as the company announced positive late stage results of its Osteosarcoma drug L-MTP-PE. ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1208089 Wed, 06 Feb 2008 04:39:00 +0100 1208089 http://www.medworm.com/index.php?rid=1208090&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F229972763%2Fshould-hospital-emergency-rooms-adopt.html by Doug Cress Med Tech Sentinel According to researchers at the Cambridge Health Alliance and Harvard Medical School, the median wait time in hospital emergency rooms increased 36% from 1997 to 2004, to an average of 30 minutes. Particularly... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1208090 Wed, 06 Feb 2008 01:27:00 +0100 1208090 http://www.medworm.com/index.php?rid=1208091&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F229868634%2Ftuesdays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology IDM PHARMA INC [IDMI] +234.21% OSTEOLOGIX INC [OLGX.OB] +36.36% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1208091 Tue, 05 Feb 2008 22:10:00 +0100 1208091 http://www.medworm.com/index.php?rid=1204763&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F229330319%2Fbiocryst-fugheddaboudit.html by Michael Shulman BiotechBlitz I rarely if ever write about stocks I recommend in my service. This is a point-and-shoot blog -- I point, you shoot -- but today I want to discuss a company I had recommended and just closed, BioCryst (BCRX).... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1204763 Tue, 05 Feb 2008 03:52:00 +0100 1204763 http://www.medworm.com/index.php?rid=1204764&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F229170123%2Fmondays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ACHILLION PHARMACEUT [ACHN] +22.68% NASTECH PHARM CO [NSTK] +15.22% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1204764 Mon, 04 Feb 2008 21:52:00 +0100 1204764 http://www.medworm.com/index.php?rid=1200752&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F228887349%2Fhospital-dangers.html by David E. Williams Health Business Blog Turns out installing alcohol-based handwashing gel dispensers in hospitals and encouraging staff to use them isn’t enough to prevent infections. Rings and long fingernails keep hands and dirty and other... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1200752 Mon, 04 Feb 2008 12:54:00 +0100 1200752 http://www.medworm.com/index.php?rid=1198758&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F228695768%2Fpharma-news-briefs.html by Aaron Barkoff Orange Book Blog Earlier this week, FDA released its highly anticipated response concerning granisetron 180-day exclusivity. This marks the first time that FDA has interpreted the "failure to market" forfeiture provisions of... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1198758 Mon, 04 Feb 2008 03:54:00 +0100 1198758 http://www.medworm.com/index.php?rid=1196015&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F227480061%2Ffridays-top-biotech-medical-stocks.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ACHILLION PHARMACEUT [ACHN] +41.21% STEMCELLS INC [STEM] +14.18% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1196015 Fri, 01 Feb 2008 21:32:00 +0100 1196015 http://www.medworm.com/index.php?rid=1192920&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226950761%2Fbiowatch-stock-alert-somanetics-jumps.html by H.S. Ayoub, DMD BioHealth Investor Shares of Somanetics Corp (SMTS) jumped 6.82% on Thursday as volume surged almost three times the three-month daily average! There were no news or any significant events that could be detected. Somanetics... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1192920 Fri, 01 Feb 2008 02:07:00 +0100 1192920 http://www.medworm.com/index.php?rid=1192921&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226803145%2Ftested-on-young-used-on-old.html by David E. Williams Health business blog Ever notice that medical devices are tested on non-Medicare populations and then paid for mostly by Medicare? Dr. Rita F. Redberg did. See (Medicare coverage decisions often based on trials in... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1192921 Thu, 31 Jan 2008 21:40:00 +0100 1192921 http://www.medworm.com/index.php?rid=1192922&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226803148%2Fmccain-is-frontrunner-tea-leaves-for.html by Mark S. Senak Eye On FDA Last night, John McCain won the Florida primary, clearly putting him in the status of front runner in the Republican Party. Hillary Clinton won Florida, even though that is an empty victory as far as delegates, she... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1192922 Thu, 31 Jan 2008 21:36:00 +0100 1192922 http://www.medworm.com/index.php?rid=1192923&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226803149%2Fthursdays-top-biotech-medical-stocks_31.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ATHERSYS INC [ATHX] +14.16% SUNESIS PHARMACEUTIC [SNSS] +14.04% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1192923 Thu, 31 Jan 2008 21:29:00 +0100 1192923 http://www.medworm.com/index.php?rid=1190088&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226136733%2Feu-hedge-pharmion-and-celgene.html by Adam Rubenstein CLSDF A very interesting few days for Pharmion (NASDAQ: PHRM) and Celgene (NASDAQ: CELG) and how they are faring in their product approval efforts in Europe. The European Medicines Agency issued a positive opinion to... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1190088 Wed, 30 Jan 2008 21:47:00 +0100 1190088 http://www.medworm.com/index.php?rid=1190089&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226136734%2Fschering-plough-relief-on-partner.html by Jon C. Ogg 24/7 Wall St. Schering-Plough Corp. (SGP) is probably breathing a sigh of relief this morning after Merck's earnings as it is partners with the drug giant on Vytorin and Zetia for cholesterol treatments. The combined Vytorin &... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1190089 Wed, 30 Jan 2008 21:42:00 +0100 1190089 http://www.medworm.com/index.php?rid=1190090&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F226123012%2Fwednesdays-top-biotech-medical-stocks_30.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ONCOTHYREON [ONTY] +48.06% METABASIS THERAPEUTI [MBRX] +30.86% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1190090 Wed, 30 Jan 2008 21:34:00 +0100 1190090 http://www.medworm.com/index.php?rid=1188761&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F225867711%2Fwuxi-pharmatech-puts-squeeze-on.html by Richard Daverman, PhD ChinaBio Today WuXi PharmaTech (WX) held a conference yesterday with its suppliers. Following a classic good-news/bad-news theme, the Shanghai-based CRO told its suppliers that it expected to increase spending between... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1188761 Wed, 30 Jan 2008 11:39:00 +0100 1188761 http://www.medworm.com/index.php?rid=1187238&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F225494731%2Ftuesdays-top-biotech-medical-stocks_29.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology OPEXA THERAPEUTICS [OPXA] +27.39% STEMCELLS INC [STEM] +19.09% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1187238 Tue, 29 Jan 2008 22:06:00 +0100 1187238 http://www.medworm.com/index.php?rid=1184742&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F224828285%2Fbreast-cancer-screening-co-pay-could.html by Doug Cress Med Tech Sentinel A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms. The study examined 366,475 women... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1184742 Mon, 28 Jan 2008 21:52:00 +0100 1184742 http://www.medworm.com/index.php?rid=1184743&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F224828286%2Fmondays-top-biotech-medical-stocks_28.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology ACORDA THERAPEUTICS [ACOR] +25.25% TRANSDEL PHARMACTL [TDLP.OB]... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1184743 Mon, 28 Jan 2008 21:45:00 +0100 1184743 http://www.medworm.com/index.php?rid=1177891&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F223162077%2Ftragedy-of-nitromed.html by Michael Shulman BiotechBlitz Skip this today if you are looking for investment ideas – I am venting today. Two days ago I sat on a set of Fox Business Channel in Washington and was to be part of a discussion that never happened – and before... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1177891 Fri, 25 Jan 2008 21:47:00 +0100 1177891 http://www.medworm.com/index.php?rid=1177892&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F223162078%2Ffridays-top-biotech-medical-stocks_25.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology GENETIC TECH SPON [GENE] +21.21% COMBINATORX [CRXX] +17.31% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1177892 Fri, 25 Jan 2008 21:40:00 +0100 1177892 http://www.medworm.com/index.php?rid=1176184&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F222547223%2Fimage-gently-or-when-diagnostic-is.html by David E. Williams Health business blog From the time I was little I had an awareness of the potential dangers of medical X-rays. My mom was always careful to limit the number and frequency of dental x-rays she let us have, and luckily we... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1176184 Thu, 24 Jan 2008 22:11:00 +0100 1176184 http://www.medworm.com/index.php?rid=1176185&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F222531738%2Fppd-opens-central-lab-services-unit-in.html by Richard Daverman, PhD ChinaBio Today PPD, Inc. (PPDI), a $5.3 billion CRO headquartered in Wilmington, NC, will expand its presence in China, opening a global central lab services unit in Beijing in conjunction with Peking Union Lawke... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1176185 Thu, 24 Jan 2008 22:08:00 +0100 1176185 http://www.medworm.com/index.php?rid=1176186&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F222531739%2Fthursdays-top-biotech-medical-stocks_24.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology METABASIS THERAPEUTI [MBRX] +17.86% CYTRX CP [CYTR] +17.49% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1176186 Thu, 24 Jan 2008 22:01:00 +0100 1176186 http://www.medworm.com/index.php?rid=1173445&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F221896962%2Fhep-c-developments-lead-biotechs-down.html by H.S. Ayoub, DMD BioHealth Investor The Dow Jones was down by 450 points early Wednesday before finishing the day up by almost 300 points in a second wild trading session in a row since the Fed cut rates by 75 points early Monday. Nasdaq also... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1173445 Wed, 23 Jan 2008 22:01:00 +0100 1173445 http://www.medworm.com/index.php?rid=1173446&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F221896963%2Fwednesdays-top-biotech-medical-stocks_23.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology OPEXA THERAPEUTICS [OPXA] +63.03% HEMOBIOTECH INC [HMBT.OB] +16.36% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1173446 Wed, 23 Jan 2008 21:53:00 +0100 1173446 http://www.medworm.com/index.php?rid=1170208&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F221247810%2Fnanomaterial-coatings-help-drugs-bypass.html by Doug Cress Med Tech Sentinel A new study published in the January issue of ACS Nano offers insight into cutting edge world of drug delivery research. In the study, UCLA and Northwestern University researchers used nanoscale polymer film... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1170208 Tue, 22 Jan 2008 22:16:00 +0100 1170208 http://www.medworm.com/index.php?rid=1170209&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F221247811%2Ftuesdays-top-biotech-medical-stocks_22.html by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top stocks: Subscribe by Email Subscribe by Feed Biotechnology CARDIUM THERAPEUTICS [CXM] +10.61% MICROMET INC [MITI] +10.59% ... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1170209 Tue, 22 Jan 2008 21:56:00 +0100 1170209 http://www.medworm.com/index.php?rid=1170210&cid=s_35775_34_f&fid=35775&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBiohealthInvestor%2F%7E3%2F220930290%2Finhaled-insulin-alkermeslilly-mannkind.html by Michael Shulman Biotech Blitz Given market conditions, consider this an exercise in cognitive dissonance or willful denial or some other over used term. But the topic here is biotech and life sciences, where successes typically overcome all... (click article title to read more...) (Source: BioHealth Investor) BioHealth Investor info http://www.medworm.com/rss/comments.php?id=1170210 Tue, 22 Jan 2008 11:34:00 +0100 1170210